George Yancopoulos (L) and Len Schleifer (Regeneron)
Regeneron's Schleifer, Yancopoulos set their company's ambitions sky high with $1.4B on the table in performance awards
One of the true success stories in biopharma, New York’s Regeneron has built a $51 billion market cap under the watchful eyes of co-founders and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
